SPONTANEOUS RESOLUTION OF MACULAR EPIRETINAL MEMBRANES AFTER @entity941 POTENTIATED XXXX LASER TREATMENT OF VON HIPPEL-LINDAU ASSOCIATED RETINAL HEMANGIOMAS: CASE REPORT AND REVIEW OF LITERATURE.

@entity1 @entity227 @entity2695 @entity2479 @entity8702 @entity941 @entity3917 @entity280 @entity3503
PURPOSE: To illustrate spontaneous resolution of macular epiretinal membranes and inactivation of retinal @entity2695 exudation after @entity941 potentiated @entity3503 laser treatment of bilateral @entity8702 in a @entity1 with a de novo heterozygous deletion in Exon 2 of the @entity280 gene. METHODS: Interventional case report. RESULTS: A 23-year-old @entity1 with subjective @entity227 , @entity3917 , and glare. On presentation, visual acuity was 20/20 in the right eye and 20/25 in the left eye with metamorphopsia. On the basis of bilateral @entity2479 on clinical examination and characterization with multimodal imaging, a diagnosis of @entity280 was made. Genetic testing identified a de novo, disease-causing heterozygous deletion in Exon 2 of the @entity280 gene. The @entity1 underwent 4 sessions of @entity941 potentiated 532 nm @entity3503 green laser treatment directed at @entity2479 . No adverse sequelae of laser treatment were noted. Seven months after the initial presentation, the @entity1 's vision was 20/20 in both eyes with interval resolution of metamorphopsia. There was spontaneous resolution of a macular epiretinal membrane with normalization of the macular retinal microstructure. The @entity2479 in both eyes appeared inactive, and no new lesions were noted. CONCLUSION: @entity941 potentiated @entity3503 laser successfully treated bilateral @entity2479 in our @entity1 with @entity280 . Additional studies to characterize the full clinical potential of @entity941 potentiated @entity3503 laser therapy may be warranted.
